{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:15:58Z","timestamp":1785575758590,"version":"3.56.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007700","name":"UMFCD","doi-asserted-by":"publisher","award":["19.714\/03.08.2021"],"award-info":[{"award-number":["19.714\/03.08.2021"]}],"id":[{"id":"10.13039\/501100007700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006730","name":"Romanian Government Ministry of Education and Research","doi-asserted-by":"publisher","award":["10N\/2023"],"award-info":[{"award-number":["10N\/2023"]}],"id":[{"id":"10.13039\/501100006730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek Vlaanderen","doi-asserted-by":"publisher","award":["1805523N"],"award-info":[{"award-number":["1805523N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009242","name":"DGOS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008909","name":"Universitatea de Medicin\u0103 \u015fi Farmacie din T\u00eergu Mure\u0219","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaip.2026.03.016","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:49:28Z","timestamp":1774583368000},"page":"1389-1398.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Performance of the I3A Scoring System for Risk Stratification in a Retrospective Cohort of Children With Ibuprofen-Induced NSAID Hypersensitivity"],"prefix":"10.1016","volume":"14","author":[{"given":"Ileana-Maria","family":"Ghiordanescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliana","family":"Cioc\u0103nea-Teodorescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Schrijvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Maria","family":"Forsea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cezara","family":"Motei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Hoarau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Demoly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.03.016_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/all.12774","article-title":"Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group","volume":"71","author":"Gomes","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib2","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaip.2015.05.012","article-title":"Drug-induced anaphylaxis in Latin American countries","volume":"3","author":"Jares","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.5415\/apallergy.2013.3.1.29","article-title":"Paediatric anaphylaxis in a Singaporean children cohort: changing food allergy triggers over time","volume":"3","author":"Liew","year":"2013","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1398-9995.1980.tb01730.x","article-title":"Aspirin intolerance and recurrent urticaria in normal adults and children: epidemiology and review","volume":"35","author":"Settipane","year":"1980","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib5","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/all.12941","article-title":"Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA2 LEN) survey","volume":"71","author":"Makowska","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib6","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/pai.12915","article-title":"EAACI\/ENDA Position Paper: diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents","volume":"29","author":"Kidon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib7","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1399-3038.2004.00159.x","article-title":"Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood","volume":"15","author":"S\u00e1nchez-Borges","year":"2004","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib8","first-page":"114","article-title":"Nonsteroidal anti-inflammatory drug hypersensitivity in preschool children","volume":"3","author":"Kidon","year":"2007","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2024.08.043","article-title":"Different phenotypes of nonsteroidal anti-inflammatory drug hypersensitivity in children and negative predictive value of drug provocation test","volume":"12","author":"Paladini","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000438992","article-title":"Different phenotypes of non-steroidal anti-inflammatory drug hypersensitivity during childhood","volume":"167","author":"Cavkaytar","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1365-2044.2000.01280.x","article-title":"Use of diclofenac in children with asthma","volume":"55","author":"Short","year":"2000","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jaip.2026.03.016_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jpeds.2005.03.055","article-title":"The prevalence of ibuprofen-sensitive asthma in children: a randomized controlled bronchoprovocation challenge study","volume":"147","author":"Debley","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaip.2026.03.016_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.aller.2016.04.004","article-title":"Non-steroidal anti-inflammatory drug hypersensitivity in children","volume":"45","author":"Alves","year":"2017","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2026.03.016_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.anai.2020.04.003","article-title":"Results of NSAID provocation tests and difficulties in the classification of children with nonsteroidal anti-inflammatory drug hypersensitivity","volume":"125","author":"Yilmaz Topal","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib15","doi-asserted-by":"crossref","first-page":"77","DOI":"10.23822\/EurAnnACI.1764-1489.299","article-title":"Hypersensitivity to non-steroidal anti-inflammatory drugs on a pediatric Portuguese cohort","volume":"57","author":"Silva","year":"2025","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaip.2019.10.049","article-title":"A multicenter retrospective study on hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) Group","volume":"8","author":"Mori","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000526981","article-title":"Hypersensitivity to ibuprofen: real-life experience in children with history of suspected immediate reactions","volume":"184","author":"Sipahi Cimen","year":"2023","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib18","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1542\/peds.110.5.e53","article-title":"Reported adverse drug events in infants and children under 2 years of age","volume":"110","author":"Moore","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2026.03.016_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005109","article-title":"Risk of asthma exacerbation associated with nonsteroidal anti-inflammatory drugs in childhood asthma: a nationwide population-based cohort study in Taiwan","volume":"95","author":"Lo","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaip.2026.03.016_bib20","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/all.15996","article-title":"EAACI\/ENDA position paper on drug provocation testing","volume":"79","author":"Barbaud","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/pai.12039","article-title":"Drug provocation tests in the diagnosis of hypersensitivity reactions to non-steroidal anti-inflammatory drugs in children","volume":"24","author":"Zambonino","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/pai.12980","article-title":"Characteristics of NSAID-induced hypersensitivity reactions in childhood","volume":"30","author":"Cavkaytar","year":"2019","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib23","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/pai.12596","article-title":"Phenotypical characterization of children with hypersensitivity reactions to NSAIDs","volume":"27","author":"Cousin","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4168\/aair.2015.7.4.312","article-title":"Seven steps to the diagnosis of NSAIDs hypersensitivity: how to apply a new classification in real practice?","volume":"7","author":"Kowalski","year":"2015","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaip.2026.03.016_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaip.2024.11.022","article-title":"Guiding drug provocation testing for ibuprofen hypersensitivity in a pediatric population: development of the I3A risk-stratification tool","volume":"13","author":"Stehlin","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib26","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1016\/j.jaip.2025.07.007","article-title":"Development of a risk-stratification tool for nonsteroidal anti-inflammatory drug hypersensitivity on a large cohort","volume":"13","author":"Ghiordanescu","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib27","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7326\/0003-4819-140-12-200406150-00009","article-title":"Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction","volume":"140","author":"Messaad","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2026.03.016_bib28","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1111\/all.14075","article-title":"Data-driven step doses for drug provocation tests to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Nohra","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World Allergy Organization anaphylaxis guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2026.03.016_bib31","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Do\u00f1a","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000337660","article-title":"How can we better classify NSAID hypersensitivity reactions?--validation from a large database","volume":"159","author":"Caimmi","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib35","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s40521-015-0049-x","article-title":"NSAIDs hypersensitivity: when and how to desensitize?","volume":"2","author":"Makowska","year":"2015","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JAA.S164806","article-title":"NSAID-induced reactions: classification, prevalence, impact, and management strategies","volume":"12","author":"Blanca-Lopez","year":"2019","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib37","doi-asserted-by":"crossref","first-page":"84","DOI":"10.15586\/aei.v51i5.946","article-title":"Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in adults: beyond current classification","volume":"51","author":"\u00c7er\u00e7i","year":"2023","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaip.2026.03.016_bib38","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jaip.2023.03.048","article-title":"Intersection of drug allergy and food allergy","volume":"11","author":"Greenberger","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib39","doi-asserted-by":"crossref","first-page":"S841","DOI":"10.4103\/jpbs.JPBS_251_19","article-title":"Prescribing of nonsteroidal anti-inflammatory drugs, tramadol, and opioids in children: patterns of its utilization","volume":"12","author":"Zin","year":"2020","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.jaip.2026.03.016_bib40","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.alit.2016.10.004","article-title":"Discrepancies in the diagnosis and classification of nonsteroidal anti-inflammatory drug hypersensitivity reactions in children","volume":"66","author":"Arikoglu","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2026.03.016_bib41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/all.12539","article-title":"Challenge-proven aspirin hypersensitivity in children with chronic spontaneous urticaria","volume":"70","author":"Cavkaytar","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2165\/00128071-200203090-00002","article-title":"NSAID-induced urticaria and angioedema: a reappraisal of its clinical management","volume":"3","author":"S\u00e1nchez-Borges","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2026.03.016_bib43","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1542\/peds.2005-0969","article-title":"Early presentation with angioedema and urticaria in cross-reactive hypersensitivity to nonsteroidal antiinflammatory drugs among young, Asian, atopic children","volume":"116","author":"Kidon","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2026.03.016_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.12296","article-title":"Risk factors of NSAID-exacerbated respiratory disease: a population-based study","volume":"13","author":"Helev\u00e4","year":"2023","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib45","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1081-1206(10)62748-2","article-title":"Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity","volume":"84","author":"S\u00e1nchez-Borges","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib46","first-page":"48","article-title":"Single NSAID hypersensitivity is associated with atopic status","volume":"47","author":"Asero","year":"2015","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2500\/aap.2016.37.3917","article-title":"The value of the clinical history for the diagnosis of immediate nonsteroidal anti-inflammatory drug hypersensitivity and safe alternative drugs in children","volume":"37","author":"Topal","year":"2016","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2026.03.016_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000452627","article-title":"Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs among adults: clinical features and risk factors for diagnosis confirmation","volume":"171","author":"Rebelo Gomes","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1365-2222.2010.03648.x","article-title":"Assessing potential determinants of positive provocation tests in subjects with NSAID hypersensitivity","volume":"41","author":"Viola","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaip.2022.01.049","article-title":"Aspirin\/NSAID challenge should be performed routinely in patients with self-reported aspirin\/NSAID allergy","volume":"10","author":"White","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib51","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaip.2017.08.029","article-title":"Acetyl salicylic acid challenge in children with hypersensitivity reactions to nonsteroidal anti-inflammatory drugs differentiates between cross-intolerant and selective responders","volume":"6","author":"Blanca-L\u00f3pez","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib52","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13052-024-01694-x","article-title":"Risk factors for drug hypersensitivity reactions in children","volume":"50","author":"Mori","year":"2024","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jaip.2026.03.016_bib53","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1542\/peds.69.6.810","article-title":"Aspirin and Reye syndrome","volume":"69","author":"Fulginiti","year":"1982","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2026.03.016_bib54","article-title":"Epidemiology and natural history of atopic diseases","volume":"2","author":"Thomsen","year":"2015","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.jaip.2026.03.016_bib55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000475499","article-title":"Influence of intrinsic and lifestyle factors on the development of IgE sensitization","volume":"173","author":"Stemeseder","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib56","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/all.14032","article-title":"Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs","volume":"75","author":"Do\u00f1a","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/JAA.S164806","article-title":"NSAID-induced reactions: classification, prevalence, impact, and management strategies","volume":"12","author":"Blanca-L\u00f3pez","year":"2019","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-exacerbated respiratory disease (N-ERD)\u2014a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/pai.12915","article-title":"EAACI\/ENDA Position Paper: diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents","volume":"29","author":"Kidon","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib61","doi-asserted-by":"crossref","first-page":"84","DOI":"10.15586\/aei.v51i5.946","article-title":"Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs in adults: beyond current classification","volume":"51","author":"\u00c7er\u00e7i","year":"2023","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.jaip.2026.03.016_bib62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s40521-015-0049-x","article-title":"NSAIDs hypersensitivity: when and how to desensitize?","volume":"2","author":"Makowska","year":"2015","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000337660","article-title":"How can we better classify NSAID hypersensitivity reactions? \u2013 Validation from a large database","volume":"159","author":"Caimmi","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib64","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.iac.2004.03.001","article-title":"Aspirin and NSAID sensitivity","volume":"24","author":"Stevenson","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2026.03.016_bib65","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/all.13075","article-title":"Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease","volume":"72","author":"Lee","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib66","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib67","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.jaip.2023.03.048","article-title":"Intersection of drug allergy and food allergy","volume":"11","author":"Greenberger","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib68","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib69","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report\u2014Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.03.016_bib70","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/all.15032","article-title":"EAACI guidelines: Anaphylaxis (2021 update)","volume":"77","author":"Muraro","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2020.100472","article-title":"World Allergy Organization Anaphylaxis Guidance 2020","volume":"13","author":"Cardona","year":"2020","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2026.03.016_bib72","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.vaccine.2022.11.027","article-title":"Anaphylaxis: revision of the Brighton collaboration case definition","volume":"41","author":"Gold","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.jaip.2026.03.016_bib73","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jaip.2024.11.022","article-title":"Guiding drug provocation testing for ibuprofen hypersensitivity in a pediatric population: development of the I3A risk-stratification tool","volume":"13","author":"Stehlin","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.03.016_bib74","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.7326\/0003-4819-140-12-200406150-00009","article-title":"Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction","volume":"140","author":"Messaad","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2026.03.016_bib75","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.03.016_bib76","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/all.15996","article-title":"EAACI\/ENDA position paper on drug provocation testing","volume":"79","author":"Barbaud","year":"2024","journal-title":"Allergy"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826002503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826002503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:25:49Z","timestamp":1781825149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826002503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213219826002503"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.03.016","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Performance of the I3A Scoring System for Risk Stratification in a Retrospective Cohort of Children With Ibuprofen-Induced NSAID Hypersensitivity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}